About Kentucky Eye Institute
"Since 1970, Kentucky Eye Institute has provided world-class comprehensive eye care to the central, northern, eastern, and southern Kentucky regions. With nine office locations, Kentucky Eye Institute is easily accessible to most patients. Our goal is to be your provider of choice for surgical and consultative intervention. At KEI, we have a vision for excellence and a heart for service."
Clinical Trials at Kentucky Eye Institute
During the past decade, Kentucky Eye Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kentucky Eye Institute" #1 sponsor was "Shire" with 2 trials, followed by "Sight Sciences, Inc." with 2 trials
sponsored, "Surface Ophthalmics, Inc." with 2 trials sponsored, "Claris Biotherapeutics, Inc." with 1 trials sponsored and "Dompé Farmaceutici S.p.A"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
Clinical Trials Conditions at Kentucky Eye Institute
According to Clinical.Site data, the most researched conditions in "Kentucky Eye Institute" are
"Dry Eye" (2 trials), "Dry Eye Disease" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Blepharitis" (1 trials). Many other conditions were trialed in "Kentucky Eye Institute" in a lesser frequency.
Clinical Trials Intervention Types at Kentucky Eye Institute
Most popular intervention types in "Kentucky Eye Institute" are "Drug" (7 trials), "Other" (4 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "0.02% Betamethasone Sodium Phosphate" (1 trials) and "0.04% Betamethasone Sodium Phosphate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kentucky Eye Institute
The vast majority of trials in "Kentucky Eye Institute" are
10 trials for "All" genders.
Clinical Trials Status at Kentucky Eye Institute
Currently, there are NaN active trials in "Kentucky Eye Institute".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Kentucky Eye Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kentucky Eye Institute, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".